Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Verdonck

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Immunology|June 1, 1996
Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contactH G Otten, B Bor, C Ververs, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2005
Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantationE Meijer, A W Dekker, H M Lokhorst, et al.
British Journal of Haematology|September 21, 2000
Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeatsR A de Weger, M G Tilanus, K C Scheidel, et al.
FEBS Letters|September 23, 1991
Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cellsE C Heesbeen, L F Verdonck, S W Hermans, et al.
Bone Marrow Transplantation|April 10, 1999
Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantationR van der Griend, L F Verdonck, E J Petersen, et al.
Bone Marrow Transplantation|June 1, 1987
Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantationL F Verdonck, Y C de Graan-Hentzen, A W Dekker, et al.
British Journal of Haematology|May 1, 1994
Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filtersH C van Prooijen, J J Visser, W R van Oostendorp, et al.
Cancer|June 15, 1994
Posttransplant T-cell lymphoma. Report of three cases and a review of the literatureJ van Gorp, H Doornewaard, L F Verdonck, et al.
Histopathology|March 26, 2003
Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantationM R Canninga-van Dijk, C J Sanders, L F Verdonck, et al.
Histopathology|September 1, 1986
Monotypic immunoglobulin E plasma cells in an allogeneic bone marrow transplant recipientH J Schuurman, L F Verdonck, J G Geertzema, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Immunology|June 1, 1996
Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contactH G Otten, B Bor, C Ververs, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2005
Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantationE Meijer, A W Dekker, H M Lokhorst, et al.
British Journal of Haematology|September 21, 2000
Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeatsR A de Weger, M G Tilanus, K C Scheidel, et al.
FEBS Letters|September 23, 1991
Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cellsE C Heesbeen, L F Verdonck, S W Hermans, et al.
Bone Marrow Transplantation|April 10, 1999
Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantationR van der Griend, L F Verdonck, E J Petersen, et al.
Bone Marrow Transplantation|June 1, 1987
Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantationL F Verdonck, Y C de Graan-Hentzen, A W Dekker, et al.
British Journal of Haematology|May 1, 1994
Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filtersH C van Prooijen, J J Visser, W R van Oostendorp, et al.
Cancer|June 15, 1994
Posttransplant T-cell lymphoma. Report of three cases and a review of the literatureJ van Gorp, H Doornewaard, L F Verdonck, et al.
Histopathology|March 26, 2003
Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantationM R Canninga-van Dijk, C J Sanders, L F Verdonck, et al.
Histopathology|September 1, 1986
Monotypic immunoglobulin E plasma cells in an allogeneic bone marrow transplant recipientH J Schuurman, L F Verdonck, J G Geertzema, et al.
Pageof 13